Nomori H, Horio H, Fuyuno G, Kobayashi R
Department of Surgery, Saiseikai Central Hospital, Tokyo, Japan.
Chest. 1997 Mar;111(3):572-6. doi: 10.1378/chest.111.3.572.
To examine the usefulness of non-serratus-sparing antero-axillary thoracotomy (AAT) with disconnection of anterior rib cartilage for curative resection of lung cancer, we used retrospective analysis to compare mortality, morbidity, hospital stay, time for thoracic opening, postoperative pulmonary function, and chest pain between AAT and posterolateral thoracotomy (PLT). Subjects were 50 lung cancer patients who underwent lobectomy via AAT (n = 25) or PLT (n = 25), who were matched by sex and age. Chest pain was evaluated using a visual analog scale, a McGill pain questionnaire, and analgesic requirements up to 6 months after surgery. AAT offered adequate exposure for lobectomy and mediastinal lymph node dissection. No difference was observed between the AAT and PLT groups in postoperative mortality, morbidity, or hospital stay. Times for thoracic opening were significantly shorter in AAT than in PLT (p < 0.001). FEV1 and vital capacity 1 week after surgery were significantly preserved in patients with AAT compared with patients with PLT (p < 0.05). Chest pain was significantly reduced in AAT patients compared with PLT patients on 1 day and from 14 days to 6 months after surgery (p < 0.01 to p < 0.001). We conclude that AAT is a reasonable thoracotomy alternative to standard PLT for curative lung cancer resection, because of its adequate exposure, shortened opening time, diminished impairment of postoperative pulmonary function, and reduced chronic postoperative pain.
为了研究不保留前锯肌的腋下胸廓切开术(AAT)联合切断前肋软骨用于肺癌根治性切除的有效性,我们采用回顾性分析,比较了AAT与后外侧胸廓切开术(PLT)在死亡率、发病率、住院时间、开胸时间、术后肺功能及胸痛方面的差异。研究对象为50例行肺叶切除术的肺癌患者,其中25例接受AAT,25例接受PLT,两组患者按性别和年龄匹配。采用视觉模拟评分法、麦吉尔疼痛问卷及术后6个月内的镇痛需求评估胸痛情况。AAT为肺叶切除及纵隔淋巴结清扫提供了足够的暴露空间。AAT组与PLT组在术后死亡率、发病率及住院时间方面未观察到差异。AAT的开胸时间显著短于PLT(p < 0.001)。与PLT组患者相比,AAT组患者术后1周的第1秒用力呼气容积(FEV1)和肺活量得到显著保留(p < 0.05)。与PLT组患者相比,AAT组患者在术后1天及术后14天至6个月时胸痛明显减轻(p < 0.01至p < 0.001)。我们得出结论,AAT是肺癌根治性切除的一种合理的胸廓切开术替代标准PLT的术式,因为它具有足够的暴露空间、缩短的开胸时间、减轻的术后肺功能损害及减少的术后慢性疼痛。